← Human Trials & Peer-Reviewed Studies

Effect of lidocaine gel on pain from copper IUD insertion: a randomized double-blind controlled trial.

Plain-language guide to PMID 22945778 (2010): double-blind randomized controlled trial of Copper (Supplement) in 96 women.

Key Facts

PMID
22945778
Journal
Indian journal of medical sciences
Year
2010
Study type
Randomized Controlled Trial
Authors
Mohammad-Alizadeh-Charandabi S et al. (3 authors)

What This Study Did, in Plain Language

What Was Tested

Researchers studied Copper (Supplement) in this randomized controlled trial publication.

To determine the effect of lidocaine gel on pain from TCu-380AIUD insertion.

Why It Was Studied

Further study has been recommended on the effects of lidocaine (xylocaine) gel on IUD insertion pain in the recent Cochran review.

Kruskal-Wallis and linear regression in SPSS-13 were used to identify effect of lidocaine gel on the pain.

Who Took Part

The study group was 96 women.

The age groups tagged for this paper are young adults and adults, women only.

At a health center in Tabriz, Iran, 96 women were allocated into 3 groups using block randomization with 6 and 9 block sizes considering allocation concealment.

How the Study Was Run

The researchers set it up as a randomized and double-blind study.

The women were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

As a double-blind Copper (Supplement) study, the assignments were hidden from both participants and investigators until the end.

Immediately after IUD insertion, pain during the insertion was measured using 0-10 cm visual analogue scale.

What Was Measured

The subject headings attached to it are Anesthetics, Local, Gels, Intrauterine Devices, Copper, Lidocaine, Pain and Prosthesis Implantation.

What This Means in Plain Language

The paper is a randomized and double-blind study of Copper (Supplement) in 96 women.

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2010 (Indian journal of medical sciences), a journal based in India.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.